✦ LIBER ✦

Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa

✍ Scribed by S. Wendt; C. Whybra; C. Kampmann; E. Teichmann; M. Beck

Publisher: Springer
Year: 2005
Tongue: English
Weight: 83 KB
Volume: 28
Category: Article
ISSN: 0141-8955
DOI: 10.1007/s10545-005-0018-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Letter concerning “Enzyme replacement th

Letter concerning “Enzyme replacement therapy in a patient with Fabry disease and the development of IgE antibodies against agalsidase beta but not agalsidase alpha”, by Tanaka et al.

✍ Gabor E. Linthorst; Johannes M. F. G. Aerts 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 63 KB

Successful pregnancy outcome in a patien

Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome

✍ Y. Sherer; M. Dulitzki; Y. Levy; A. Livneh; Y. Shoenfeld; P. Langevitz 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 24 KB

The effect of 12-month enzyme replacemen

The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease

✍ R. J. Kalliokoski; I. Kantola; K. K. Kalliokoski; E. Engblom; J. Sundell; J. C. 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 242 KB

Outcome of enzyme replacement therapy in

Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience

✍ P. Grigorescu Sido; C. Drugan; V. Cret; C. Al-Kzouz; C. Denes; C. Coldea; A. Zim 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 299 KB

Pathological findings in a patient with

Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement

✍ Raphael Schiffmann; Amy Rapkiewicz; Mones Abu-Asab; Markus Ries; Hasan Askari; M 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 744 KB

Morphological changes in muscle tissue o

Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy

✍ Léon P. F. Winkel; Joep H. J. Kamphoven; Hannerieke J. M. P. Van Den Hout; Lies 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

## Abstract Pompe's disease (glycogen storage disease type II) is an autosomal recessive myopathy caused by lysosomal α‐glucosidase deficiency. Enzyme replacement therapy (ERT) is currently under development for this disease. We evaluated the morphological changes in muscle tissue of four children